672 views4 min read
Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research
New clinical trial will provide experiential training to therapists learning to conduct psilocybin-assisted therapy.
Clinical trial dosing will use Numinus Bioscience's Psilocybin Tea, EnfiniTea – one of the first Phase 1 clinical trials that will report on whole Psilocybe mushroom safety.
VANCOUVER, BC, Dec. 8, 2022 - Numinus Wellness ... Read More...